Literature DB >> 23733640

Pathophysiology of the diabetic kidney.

Volker Vallon1, Radko Komers.   

Abstract

Diabetes mellitus contributes greatly to morbidity, mortality, and overall health care costs. In major part, these outcomes derive from the high incidence of progressive kidney dysfunction in patients with diabetes making diabetic nephropathy a leading cause of end-stage renal disease. A better understanding of the molecular mechanism involved and of the early dysfunctions observed in the diabetic kidney may permit the development of new strategies to prevent diabetic nephropathy. Here we review the pathophysiological changes that occur in the kidney in response to hyperglycemia, including the cellular responses to high glucose and the responses in vascular, glomerular, podocyte, and tubular function. The molecular basis, characteristics, and consequences of the unique growth phenotypes observed in the diabetic kidney, including glomerular structures and tubular segments, are outlined. We delineate mechanisms of early diabetic glomerular hyperfiltration including primary vascular events as well as the primary role of tubular growth, hyperreabsorption, and tubuloglomerular communication as part of a "tubulocentric" concept of early diabetic kidney function. The latter also explains the "salt paradox" of the early diabetic kidney, that is, a unique and inverse relationship between glomerular filtration rate and dietary salt intake. The mechanisms and consequences of the intrarenal activation of the renin-angiotensin system and of diabetes-induced tubular glycogen accumulation are discussed. Moreover, we aim to link the changes that occur early in the diabetic kidney including the growth phenotype, oxidative stress, hypoxia, and formation of advanced glycation end products to mechanisms involved in progressive kidney disease.
© 2011 American Physiological Society.

Entities:  

Mesh:

Year:  2011        PMID: 23733640      PMCID: PMC6029262          DOI: 10.1002/cphy.c100049

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  748 in total

1.  Human ornithine decarboxylase-encoding loci: nucleotide sequence of the expressed gene and characterization of a pseudogene.

Authors:  N J Hickok; J Wahlfors; A Crozat; M Halmekytö; L Alhonen; J Jänne; O A Jänne
Journal:  Gene       Date:  1990-09-14       Impact factor: 3.688

2.  Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.

Authors:  K Posch; S Simecek; T C Wascher; G Jürgens; S Baumgartner-Parzer; G M Kostner; W F Graier
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

3.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

Authors:  Nozomu Tanji; Glen S Markowitz; Caifeng Fu; Thomas Kislinger; Akihiko Taguchi; Monika Pischetsrieder; David Stern; Ann Marie Schmidt; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

Review 4.  Nitric oxide and kidney oxygenation.

Authors:  Fredrik Palm; Tom Teerlink; Peter Hansell
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

Review 5.  Diabetic nephropathy: mechanisms of renal disease progression.

Authors:  Yashpal S Kanwar; Jun Wada; Lin Sun; Ping Xie; Elisabeth I Wallner; Sheldon Chen; Sumant Chugh; Farhad R Danesh
Journal:  Exp Biol Med (Maywood)       Date:  2008-01

6.  Impact of initial treatment on renal function in newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Vora; J Dolben; J D Williams; J R Peters; D R Owens
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

7.  Adenosine A(1) receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus.

Authors:  Volker Vallon; Jana Schroth; Joseph Satriano; Roland C Blantz; Scott C Thomson; Timo Rieg
Journal:  Nephron Physiol       Date:  2009-03-10

8.  Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy.

Authors:  J A O'Hare; J B Ferriss; D Brady; B Twomey; D J O'Sullivan
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

Review 9.  Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.

Authors:  Masaomi Nangaku
Journal:  Intern Med       Date:  2004-01       Impact factor: 1.271

10.  Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.

Authors:  Vasantha Kolavennu; Lixia Zeng; Hui Peng; Yin Wang; Farhad R Danesh
Journal:  Diabetes       Date:  2007-12-14       Impact factor: 9.461

View more
  76 in total

1.  Cathepsin D protects renal tubular cells from damage induced by high glucose independent of its enzymatic activity.

Authors:  Feng Du; Tian Wang; Si Li; Xin Meng; Hai-Yan Zhang; De-Tian Li; Zhen-Xian Du; Hua-Qin Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis.

Authors:  K Melissa Hallow; Yeshitila Gebremichael; Gabriel Helmlinger; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2017-02-01

Review 3.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

4.  Deep representation learning of electronic health records to unlock patient stratification at scale.

Authors:  Isotta Landi; Benjamin S Glicksberg; Hao-Chih Lee; Sarah Cherng; Giulia Landi; Matteo Danieletto; Joel T Dudley; Cesare Furlanello; Riccardo Miotto
Journal:  NPJ Digit Med       Date:  2020-07-17

5.  Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress.

Authors:  Zhen Wang; Jussara M do Carmo; Nicola Aberdein; Xinchun Zhou; Jan M Williams; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2017-03-27       Impact factor: 10.190

6.  NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes.

Authors:  Jing Yang; Jennifer S Pollock; Pamela K Carmines
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

7.  Arsenic exposure intensifies glycogen nephrosis in diabetic rats.

Authors:  Marcela Nascimento Sertorio; Ana Cláudia Ferreira Souza; Daniel Silva Sena Bastos; Felipe Couto Santos; Luiz Otávio Guimarães Ervilha; Kenner Morais Fernandes; Leandro Licursi de Oliveira; Mariana Machado-Neves
Journal:  Environ Sci Pollut Res Int       Date:  2019-03-07       Impact factor: 4.223

8.  Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.

Authors:  Aleksandar Denic; Hisham Elsherbiny; Aidan F Mullan; Bradley C Leibovich; R Houston Thompson; Luisa Ricaurte Archila; Ramya Narasimhan; Walter K Kremers; Mariam P Alexander; John C Lieske; Lilach O Lerman; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2020-09-16       Impact factor: 10.121

9.  Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress.

Authors:  Elena N Atochina-Vasserman; Asel Biktasova; Elena Abramova; Dong-Sheng Cheng; Vasiliy V Polosukhin; Harikrishna Tanjore; Saki Takahashi; Hiroko Sonoda; Liberty Foye; Christo Venkov; Sergey V Ryzhov; Sergey Novitskiy; Natalia Shlonimskaya; Masahiro Ikeda; Timothy S Blackwell; William E Lawson; Andrew J Gow; Raymond C Harris; Mikhail M Dikov; Elena E Tchekneva
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-13

Review 10.  The tubular hypothesis of nephron filtration and diabetic kidney disease.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Nat Rev Nephrol       Date:  2020-03-09       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.